Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 2
2(33.3%)
6Total
N/A(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01890330Not ApplicableCompleted

Effects of Canola Oil on Vascular and Metabolic Parameters in Individuals With Metabolic Syndrome

Role: collaborator

NCT03054779Not ApplicableCompleted

Canola Oil Multi-center Intervention Trial II

Role: collaborator

NCT02029833Not ApplicableCompleted

Canola Oil Multi-Centre Intervention Trial II

Role: collaborator

NCT02245399Not ApplicableCompleted

Canola-Mediterranean Diet Study in T2DM

Role: collaborator

NCT01348568Phase 2Completed

Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics

Role: collaborator

NCT00927199Phase 2Completed

Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors

Role: collaborator

All 6 trials loaded